Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| Reactant | 3-Chloro-2-(7-chloro-1,8-naphthyridin-2-yl)-1-isoindolinone | HCID 14182404 | — |
| Reactant | 3-(2-Oxopiperidin-1-yl)propanoic acid | HCID 19900425 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 88137067 | HCID 88137067 | 46.9% |
Reaction Steps
The procedure is as in Example 1, but starting with 3-chloro-2-(7-chloro-1,8-naphthyridin-2-yl)-1-isoindolinone (4,3 g) in anhydrous dimethylformamide (40 cc), 3-(2-oxopiperidino)propionic acid (2.2 g) and 1,8-diazabicyclo [5.4.0]undec-7-ene (2 g). After the reaction mixture has been taken up with water, the resulting mixture extracted with methylene chloride and the solvent evaporated, the residue obtained is recrystallized in acetonitrile. The product thereby obtained is purified by chromatography on silica (0.063-0.2 mm; 100 g) contained in a column 2.3 cm in diameter (eluant: methylene chloride), collecting 50-cc fractions. Fractions 56 to 64 are combined and concentrated to dryness under reduced pressure (2.7 kPa) at 20° C. The residue obtained is recrystallized in acetonitrile. 2-(7-Chloro-1,8-naphthridin-2-yl)-3-oxo-1-isoindolinyl 3-(2-oxopiperidino)propionate (2.8 g), m.p. 175° C., is thereby obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05102890 |
|---|
| Source dataset | uspto-grants-1992_04 |
|---|
| ORD ID | ord-1126b0b6c86c4f70b415c5f0769d2929 |
|---|
| Source note | uspto-grants-1992_04 |
|---|